trientine has been researched along with Ventricular Dysfunction, Left in 1 studies
Trientine: An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
TETA : An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.
2,2,2-tetramine : A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens.
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trientine treatment significantly improved cardiac function in diabetic rats with substantive LV impairment." | 1.39 | Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment. ( Choong, SY; Cooper, GJ; Cowan, BR; Gamble, GD; Li, M; Lu, J; Phillips, AR; Pickup, S; Pontré, B; Xu, H; Young, AA, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, J | 1 |
| Pontré, B | 1 |
| Pickup, S | 1 |
| Choong, SY | 1 |
| Li, M | 1 |
| Xu, H | 1 |
| Gamble, GD | 1 |
| Phillips, AR | 1 |
| Cowan, BR | 1 |
| Young, AA | 1 |
| Cooper, GJ | 1 |
1 other study available for trientine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment.
Topics: Animals; Chelating Agents; Copper; Diabetes Mellitus, Experimental; Heart; Heart Function Tests; Mal | 2013 |